{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:41:20Z","timestamp":1793148080617,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1156072"],"award-info":[{"award-number":["1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bbi.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T04:23:29Z","timestamp":1627446209000},"page":"193-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"special_numbering":"C","title":["Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability"],"prefix":"10.1016","volume":"97","author":[{"given":"Marco","family":"Solmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Suresh Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6239-5691","authenticated-orcid":false,"given":"Emanuele F.","family":"Osimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bortolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Croatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2513-2718","authenticated-orcid":false,"given":"Alessandro","family":"Miola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-0053","authenticated-orcid":false,"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-5091","authenticated-orcid":false,"given":"Carmine M.","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Il","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5554-6946","authenticated-orcid":false,"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-5671","authenticated-orcid":false,"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.07.014_b0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.bbi.2017.06.005","article-title":"Childhood maltreatment severity is associated with elevated C-reactive protein and body mass index in adults with schizophrenia and bipolar diagnoses","volume":"65","author":"Aas","year":"2017","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2021.07.014_b0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.bbi.2021.07.014_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bdi.12259","article-title":"Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls","volume":"17","author":"Bai","year":"2015","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.014_b0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","article-title":"Increased plasma levels of soluble TNF receptor i in patients with bipolar disorder","volume":"261","author":"Barbosa","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.014_b0025","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jpsychires.2013.08.019","article-title":"Altered intracellular signaling cascades in peripheral blood mononuclear cells from BD patients","volume":"47","author":"Barbosa","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"1-3","key":"10.1016\/j.bbi.2021.07.014_b0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jad.2011.12.034","article-title":"Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers","volume":"137","author":"Barbosa","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpsychires.2011.11.010","article-title":"Increased levels of adipokines in bipolar disorder","volume":"46","author":"Barbosa","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.9758\/cpn.2017.15.3.269","article-title":"Plasma levels of Tumor Necrosis factor superfamily molecules are increased in bipolar disorder","volume":"15","author":"Barbosa","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.014_b0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.03.004","article-title":"Attention should be given to multiplicity issues in systematic reviews","volume":"61","author":"Bender","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbi.2021.07.014_b0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.014_b0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2215-0366(20)30155-3","article-title":"Anti-inflammatory treatment of bipolar depression: promise and disappointment","volume":"7","author":"Berk","year":"2020","journal-title":"Lancet Psychiat."},{"key":"10.1016\/j.bbi.2021.07.014_b0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jad.2004.01.007","article-title":"Cytokine production in bipolar affective disorder patients under lithium treatment","volume":"82","author":"Boufidou","year":"2004","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/jamapsychiatry.2017.2663","article-title":"Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: a Meta-analysis","volume":"74","author":"Brugger","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.014_b0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1906193","article-title":"Bipolar Disorder","volume":"383","author":"Carvalho","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2021.07.014_b0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41398-020-0835-5","article-title":"Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders","volume":"10","author":"Carvalho","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0085","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jad.2018.11.018","article-title":"Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder","volume":"245","author":"Chakrabarty","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.014_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/15622975.2016.1155746","article-title":"C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder","volume":"18","author":"Chang","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0095","unstructured":"Civil Arslan, F., Tiryaki, A., \u00d6zkorumak Karag\u00fczel, E., Aral, G., Sar\u0131o\u011flu, O.., \u0130nce, \u0130., \u00c7ankaya, S., Alver, A., n.d. The Relationship of Interleukin-18 and Interleukin-6 Levels with Cognitive Functions in Bipolar Disorder. Turk Psikiyatr. Derg 28(2), 81\u201388."},{"key":"10.1016\/j.bbi.2021.07.014_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2021.07.014_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","article-title":"Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder","volume":"258","author":"Cunha","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.014_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.psychres.2017.01.061","article-title":"Peripheral insulin-like growth factor 1 in bipolar disorder","volume":"250","author":"da Silva","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-reactive protein alterations in bipolar disorder: a meta-analysis","volume":"76","author":"Darg\u00e9l","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.014_b0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/039463200802100208","article-title":"Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder","volume":"21","author":"De Berardis","year":"2008","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.014_b0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","article-title":"Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder","volume":"31","author":"Dickerson","year":"2007","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hup.2301","article-title":"Levels of TNF-\u03b1, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder","volume":"28","author":"Doganavsargil-Baysal","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.bbi.2021.07.014_b0140","unstructured":"Eisler, Z., Kert\u00e9sz, J., 2007. Fluctuation scaling in complex systems."},{"key":"10.1016\/j.bbi.2021.07.014_b0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fpsyt.2020.00112","article-title":"Editorial: back to the future: on the road towards precision Psychiatry","volume":"11","author":"Fernandes","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0150","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","article-title":"The new field of \u2018precision psychiatry\u2019","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.bbi.2021.07.014_b0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0160","doi-asserted-by":"crossref","DOI":"10.1517\/13543784.2014.998334","article-title":"Novel investigational drugs targeting IL-6 signaling for the treatment of depression","author":"Fonseka","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbi.2021.07.014_b0165","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.psychres.2018.03.074","article-title":"Semistructured Interview for Bipolar At Risk States (SIBARS)","volume":"264","author":"Fusar-Poli","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1017\/S0033291717002744","article-title":"Mood disorders and circulating levels of inflammatory markers in a longitudinal population-based study","volume":"48","author":"Glaus","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2021.07.014_b0175","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","author":"Goldsmith","year":"2016","journal-title":"Molecular Psychiatry. Nature Publishing Group"},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jad.2010.04.027","article-title":"Cytokine levels in euthymic bipolar patients","volume":"126","author":"Guloksuz","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpsychires.2020.03.015","article-title":"Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017","volume":"125","author":"He","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0190","doi-asserted-by":"crossref","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., Welch, V., 2020. Cochrane Handbook for Systematic Reviews of Interventions | Cochrane Training [WWW Document]. URL https:\/\/training.cochrane.org\/cochrane-handbook-systematic-reviews-interventions#how-to-cite (accessed 10.29.20).","DOI":"10.1002\/9781119536604"},{"issue":"29","key":"10.1016\/j.bbi.2021.07.014_b0195","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1002\/sim.3427","article-title":"Meta-analysis of skewed data: combining results reported on log-transformed or raw scales","volume":"27","author":"Higgins","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.bbi.2021.07.014_b0200","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jpsychires.2011.08.003","article-title":"Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia","volume":"45","author":"Hope","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2015.04.004","article-title":"Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls","volume":"165","author":"Hope","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0210","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1399-5618.2009.00757.x","article-title":"Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor","volume":"11","author":"Hope","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-0327(97)00180-8","article-title":"Positive and negative acute phase proteins in affective subtypes","volume":"49","author":"Hornig","year":"1998","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0220","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pnpbp.2006.09.010","article-title":"High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania","volume":"31","author":"Huang","year":"2007","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0225","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2265.2007.02963.x","article-title":"Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder","volume":"67","author":"Hung","year":"2007","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.bbi.2021.07.014_b0230","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","article-title":"Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial","volume":"7","author":"Husain","year":"2020","journal-title":"The Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar i disorder - results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.014_b0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpsychires.2010.05.015","article-title":"Peripheral biomarkers and illness activity in bipolar disorder","volume":"45","author":"Kapczinski","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0245","article-title":"Inflammation and neurodegeneration in patients with early-stage and chronic bipolar disorder","volume":"30","author":"Karabulut","year":"2019","journal-title":"Turkish J. Psychiatry"},{"issue":"04","key":"10.1016\/j.bbi.2021.07.014_b0250","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1017\/S1461145708009310","article-title":"Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder","volume":"12","author":"Kauer-Sant'Anna","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.014_b0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2015.03.027","article-title":"Causes of decreased life expectancy over the life span in bipolar disorder","volume":"180","author":"Kessing","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00066","article-title":"Inflammation, glutamate, and cognition in bipolar disorder type II: a proof of concept study","volume":"10","author":"King","year":"2019","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41398-019-0536-0","article-title":"Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder","volume":"9","author":"Koga","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.014_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1197-2","article-title":"Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms","volume":"15","author":"Lesh","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bbi.2021.07.014_b0280","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14728222.2014.888417","article-title":"Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?","volume":"18","author":"Maes","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"12","key":"10.1016\/j.bbi.2021.07.014_b0285","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","article-title":"The Compensatory Immune-Regulatory Reflex System (CIRS) in depression and bipolar disorder","volume":"55","author":"Maes","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2021.07.014_b0290","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euroneuro.2020.05.006","article-title":"Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action","volume":"36","author":"Manchia","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.014_b0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2018.04.115","article-title":"Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression","volume":"237","author":"Mao","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0300","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of Adjunctive Infliximab vs Placebo in the treatment of adults with Bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0305","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2021.07.014_b0310","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression heterogeneity and its biological underpinnings: toward immunometabolic depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.014_b0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1-3","key":"10.1016\/j.bbi.2021.07.014_b0320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2016.04.047","article-title":"Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study","volume":"175","author":"Mizuno","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.014_b0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2021.07.014_b0330","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbi.2021.07.014_b0335","doi-asserted-by":"crossref","unstructured":"Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberat\u00ee, A., Petticrew, M., Shekelle, P., Stewart, L.A., Group, P.-P., 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. doi: 10.1186\/2046-4053-4-1.","DOI":"10.1136\/bmj.g7647"},{"issue":"18","key":"10.1016\/j.bbi.2021.07.014_b0340","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","article-title":"Association between mental disorders and subsequent medical conditions","volume":"382","author":"Momen","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2021.07.014_b0345","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jneuroim.2016.10.012","article-title":"Circadian preferences, oxidative stress and inflammatory cytokines in bipolar disorder: a community study","volume":"301","author":"Mondin","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2021.07.014_b0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eurpsy.2019.02.006","article-title":"High BDNF serum levels are associated to good cognitive functioning in bipolar disorder","volume":"60","author":"Mora","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0355","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","article-title":"Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders","volume":"107","author":"Morris","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.bbi.2021.07.014_b0360","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2014.09.021","article-title":"Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients","volume":"43","author":"Munkholm","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2021.07.014_b0370","article-title":"Cardiovascular disease in patients with severe mental illness","author":"Nielsen","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbi.2021.07.014_b0375","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","article-title":"Immune variations in bipolar disorder: phasic differences","volume":"9","author":"Ortiz-Dom\u00ednguez","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0380","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2021.07.014_b0385","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796020000694","article-title":"Excess mortality and shortened life expectancy in people with major mental illnesses in Taiwan","volume":"29","author":"Pan","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.014_b0390","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bdi.12320","article-title":"Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder","volume":"17","author":"Pandey","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0395","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1080\/15622975.2016.1259498","article-title":"sVCAM-1, sICAM-1, TNF-\u03b1 and IL-6 levels in bipolar disorder type I: acute, longitudinal and therapeutic implications","volume":"19","author":"Pantovi\u0107-Stefanovi\u0107","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0400","series-title":"Neurobiology of bipolar disorder. Road to novel therapeutics","author":"Quevedo","year":"2021"},{"issue":"16","key":"10.1016\/j.bbi.2021.07.014_b0405","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1017\/S0033291718003690","article-title":"Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder","volume":"49","author":"Quid\u00e9","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2021.07.014_b0410","first-page":"599","article-title":"Activity of selected cytokines in bipolar patients during manic and depressive episodes","volume":"46","author":"Remlinger-Molenda","year":"2012","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.bbi.2021.07.014_b0415","unstructured":"Rohatgi, A., 2020. WebPlotDigitizer."},{"key":"10.1016\/j.bbi.2021.07.014_b0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2017.03.014","article-title":"Plasma interleukin-6 in remitted early bipolar I disorder and subjects at high-risk for bipolar disorder","author":"Sanjay","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.bbi.2021.07.014_b0430","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients","volume":"92","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0435","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jad.2015.12.020","article-title":"Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder","volume":"192","author":"Scola","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.07.014_b0440","article-title":"MOOSE guidelines for meta-analyses and systematic reviews of observational studies","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bbi.2021.07.014_b0445","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacc.2005.10.055","article-title":"Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein","volume":"47","author":"Suleiman","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1-2","key":"10.1016\/j.bbi.2021.07.014_b0450","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jad.2011.08.022","article-title":"Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder","volume":"136","author":"Tsai","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0455","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/24750573.2019.1584489","article-title":"Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study","volume":"29","author":"Tun\u00e7","year":"2019","journal-title":"Psychiatry Clin. Psychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.014_b0460","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2018.00250","article-title":"Markers of inflammation and monoamine metabolism indicate accelerated aging in bipolar disorder","volume":"9","author":"van den Ameele","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.014_b0465","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/wps.20309","article-title":"Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis","volume":"15","author":"Vancampfort","year":"2016","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0470","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.014_b0475","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ijnp\/pyx001","article-title":"Telomere length, oxidative stress, inflammation and BDNF levels in siblings of patients with bipolar disorder: implications for accelerated cellular aging","volume":"20","author":"Vasconcelos-Moreno","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.014_b0480","first-page":"117","article-title":"Personalized medicine applied to mental health: precision psychiatry","volume":"8","author":"Vieta","year":"2015","journal-title":"Rev. Psiquiatr. y Salud Ment. (English Ed.)"},{"issue":"4","key":"10.1016\/j.bbi.2021.07.014_b0485","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","article-title":"Serological observations in patients suffering from acute manic episodes","volume":"17","author":"Wadee","year":"2002","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.014_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw012","article-title":"The differential levels of inflammatory cytokines and bdnf among bipolar spectrum disorders","volume":"19","author":"Wang","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2021.07.014_b0495","unstructured":"WHO, n.d. International Classification of Diseases - 10 (ICD-10). Version: 2019., World Health Organization."},{"key":"10.1016\/j.bbi.2021.07.014_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2014.07.040","article-title":"Pro-inflammatory cytokines and soluble receptors in response to acute psychosocial stress: differential reactivity in bipolar disorder","author":"Wieck","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2021.07.014_b0505","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2017.03.003","article-title":"Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder","volume":"307","author":"Wiener","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2021.07.014_b0510","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.psychres.2019.01.100","article-title":"Interleukin-6 and Interleukin-10 in mood disorders: a population-based study","volume":"273","author":"Wiener","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2021.07.014_b0515","article-title":"Circulating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: A preliminary study","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:10:48Z","timestamp":1760170248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121002786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":103,"alternative-id":["S0889159121002786"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.014","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}